QuidelOrtho Statistics
Total Valuation
QuidelOrtho has a market cap or net worth of $2.53 billion. The enterprise value is $5.10 billion.
Important Dates
The last earnings date was Wednesday, May 7, 2025, after market close.
Earnings Date | May 7, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
QuidelOrtho has 67.63 million shares outstanding. The number of shares has increased by 0.71% in one year.
Current Share Class | 67.63M |
Shares Outstanding | 67.63M |
Shares Change (YoY) | +0.71% |
Shares Change (QoQ) | +0.30% |
Owned by Insiders (%) | 0.73% |
Owned by Institutions (%) | 100.73% |
Float | 61.54M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | 14.71 |
PS Ratio | 0.91 |
Forward PS | 0.90 |
PB Ratio | 0.84 |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | 16.95 |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 1.84 |
EV / EBITDA | 9.10 |
EV / EBIT | 43.30 |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.20, with a Debt / Equity ratio of 0.90.
Current Ratio | 1.20 |
Quick Ratio | 0.54 |
Debt / Equity | 0.90 |
Debt / EBITDA | 4.38 |
Debt / FCF | n/a |
Interest Coverage | 0.63 |
Financial Efficiency
Return on equity (ROE) is -11.38% and return on invested capital (ROIC) is 1.27%.
Return on Equity (ROE) | -11.38% |
Return on Assets (ROA) | 1.12% |
Return on Invested Capital (ROIC) | 1.27% |
Return on Capital Employed (ROCE) | 2.18% |
Revenue Per Employee | $418,894 |
Profits Per Employee | -$54,348 |
Employee Count | 6,600 |
Asset Turnover | 0.42 |
Inventory Turnover | 2.56 |
Taxes
In the past 12 months, QuidelOrtho has paid $17.30 million in taxes.
Income Tax | 17.30M |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -12.18% in the last 52 weeks. The beta is 0.13, so QuidelOrtho's price volatility has been lower than the market average.
Beta (5Y) | 0.13 |
52-Week Price Change | -12.18% |
50-Day Moving Average | 32.11 |
200-Day Moving Average | 39.65 |
Relative Strength Index (RSI) | 68.06 |
Average Volume (20 Days) | 2,037,623 |
Short Selling Information
The latest short interest is 4.29 million, so 6.34% of the outstanding shares have been sold short.
Short Interest | 4.29M |
Short Previous Month | 3.80M |
Short % of Shares Out | 6.34% |
Short % of Float | 6.96% |
Short Ratio (days to cover) | 2.80 |
Income Statement
In the last 12 months, QuidelOrtho had revenue of $2.76 billion and -$358.70 million in losses. Loss per share was -$5.33.
Revenue | 2.76B |
Gross Profit | 1.30B |
Operating Income | 117.80M |
Pretax Income | -1.99B |
Net Income | -358.70M |
EBITDA | 560.70M |
EBIT | 117.80M |
Loss Per Share | -$5.33 |
Full Income Statement Balance Sheet
The company has $128.00 million in cash and $2.70 billion in debt, giving a net cash position of -$2.57 billion or -$38.00 per share.
Cash & Cash Equivalents | 128.00M |
Total Debt | 2.70B |
Net Cash | -2.57B |
Net Cash Per Share | -$38.00 |
Equity (Book Value) | 3.00B |
Book Value Per Share | 44.40 |
Working Capital | 211.00M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was $149.30 million and capital expenditures -$185.20 million, giving a free cash flow of -$35.90 million.
Operating Cash Flow | 149.30M |
Capital Expenditures | -185.20M |
Free Cash Flow | -35.90M |
FCF Per Share | -$0.53 |
Full Cash Flow Statement Margins
Gross margin is 46.94%, with operating and profit margins of 4.26% and -12.97%.
Gross Margin | 46.94% |
Operating Margin | 4.26% |
Pretax Margin | -12.35% |
Profit Margin | -12.97% |
EBITDA Margin | 20.28% |
EBIT Margin | 4.26% |
FCF Margin | n/a |
Dividends & Yields
QuidelOrtho does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -0.71% |
Shareholder Yield | -0.71% |
Earnings Yield | -14.17% |
FCF Yield | -1.42% |
Dividend Details Analyst Forecast
The average price target for QuidelOrtho is $44.43, which is 18.73% higher than the current price. The consensus rating is "Buy".
Price Target | $44.43 |
Price Target Difference | 18.73% |
Analyst Consensus | Buy |
Analyst Count | 7 |
Revenue Growth Forecast (5Y) | 2.39% |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
QuidelOrtho has an Altman Z-Score of 1.03 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 1.03 |
Piotroski F-Score | 5 |